[

mhra

]
An employee shows the Moderna coronavirus disease vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York on December 21, 2020.(Reuters file)

UK regulator approves Covid-19 vaccine from Moderna

By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON JAN 08, 2021 07:42 PM IST
Supplies will begin to be delivered from spring once Moderna expands its production capability, officials said. The vaccine will be available to people for free.
Close
Britain on Wednesday approved the exceptional use of the National Health Service test and trace COVID-19 self-test kit to detect asymptomatic coronavirus cases(REUTERS)
Britain on Wednesday approved the exceptional use of the National Health Service test and trace COVID-19 self-test kit to detect asymptomatic coronavirus cases(REUTERS)

Britain approves use of Covid-19 self-test kit

By Reuters | Posted by Ayshee Bhaduri | London
UPDATED ON DEC 23, 2020 10:55 PM IST
The Medicines and Healthcare products Regulatory Agency said that the kit uses an antigen lateral flow test (antigen LFT), which can give a result in 30 minutes.
Close
Britain began mass vaccinating its population on Tuesday in a global drive that poses one of the biggest logistical challenges in peacetime history, starting with the elderly and frontline workers.(Pixabay)
Britain began mass vaccinating its population on Tuesday in a global drive that poses one of the biggest logistical challenges in peacetime history, starting with the elderly and frontline workers.(Pixabay)

MHRA, UK: People with serious allergies must avoid Pfizer vaccine

By Reuters | Posted by Shivani Kale | London
UPDATED ON DEC 09, 2020 06:58 PM IST
UK warns people who with serious allergies with to avoid Pfizer-BioNTech Covid-19 vaccine after two people reported adverse effects on the first day of rollout.
Close
A nurse prepares a shot of the Pfizer-BioNTech Covid-19 vaccine at Guy's Hospital in London on December 8.(AP)
A nurse prepares a shot of the Pfizer-BioNTech Covid-19 vaccine at Guy's Hospital in London on December 8.(AP)

UK looking at allergic reaction to Pfizer-BioNTech vaccine

By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON DEC 09, 2020 05:18 PM IST
“We’re looking at two case reports of allergic reactions,’’said Dr June Raine, head of the UK’s medical regulatory agency as she testified on Wednesday to a Parliamentary committee. “We know from the very extensive clinical trials that this wasn’t a feature.”
Close
The United Kingdom became the first country to approve the Covid-19 vaccine created by Pfizer and BioNTech for emergency usage(Reuters File Photo)
The United Kingdom became the first country to approve the Covid-19 vaccine created by Pfizer and BioNTech for emergency usage(Reuters File Photo)

How are vaccines approved: All you need to know

By hindustantimes.com | Edited by Srivatsan K C | Hindustan Times, New Delhi
UPDATED ON DEC 03, 2020 06:50 PM IST
With the first bunch of Pfizer vaccines expected to roll out in the UK by next week, as confirmed by Health Secretary Matt Hancock, here is a look at how countries around the world are approving vaccines.
Close
The Pfizer-BioNTech Covid-19 vaccine is expected to be rolled out in the UK starting next week.(REUTERS/ FILE)
The Pfizer-BioNTech Covid-19 vaccine is expected to be rolled out in the UK starting next week.(REUTERS/ FILE)

UK first to approve Covid-19 vaccine; roll-out next week

By Prasun Sonwalkar | Hindustan Times, London
UPDATED ON DEC 02, 2020 07:02 PM IST
The Pfizer-BioNTech vaccine with 95% efficacy needs to be initially refrigerated at a temperature of minus 70 to 80 degrees Celsius, and administered in two doses, 21 days apart
Close
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken on September 9.(Reuters file)
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken on September 9.(Reuters file)

Amid test data doubts, UK seeks temporary supply of AstraZeneca/Oxford vaccine

By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON NOV 27, 2020 06:01 PM IST
The UK will be one of the first countries in the world to receive the vaccine, if authorised, with AstraZeneca expecting to have up to 4 million doses ready by the end of the year and 40mn by the end of March 2021.
Close
On Monday, AZD1222 Covid-19 vaccine developed by AstraZeneca and the Oxford University was declared to be 70 per cent effective.(Reuters)
On Monday, AZD1222 Covid-19 vaccine developed by AstraZeneca and the Oxford University was declared to be 70 per cent effective.(Reuters)

Manufacturing error in AstraZeneca-Oxford Covid-19 vaccine: What went wrong

By hindustantimes.com | Edited by Srivatsan K C | Hindustan Times, New Delhi
UPDATED ON NOV 27, 2020 05:51 PM IST
Following Britain’s health secretary Matt Hancock, secretary of state for housing, communities and local government Rober Jenrick has also assured that the UK independent regulator would thoroughly assess the Covid-19 vaccine.
Close
Pfizer spokesman Andy Widger said that the company is continuing to work closely with the MHRA and is in the process of providing the data to allow the regulator to make a full assessment.(Reuters File Photo)
Pfizer spokesman Andy Widger said that the company is continuing to work closely with the MHRA and is in the process of providing the data to allow the regulator to make a full assessment.(Reuters File Photo)

Britain asks regulator to assess Pfizer’s Covid-19 vaccine for suitability

By Reuters | Posted by Srivatsan K C | London
PUBLISHED ON NOV 21, 2020 01:23 AM IST
Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.3 million worldwide and crippled the global economy.
Close
People walk in the rain past Christmas decorations in central London on November 20.(AFP)
People walk in the rain past Christmas decorations in central London on November 20.(AFP)

UK secures early access to 355 million doses of prospective Covid-19 vaccines

By Prasun Sonwalkar | Hindustan Times, London
PUBLISHED ON NOV 21, 2020 12:26 AM IST
Health secretary Matt Hancock said on Friday that recent news from the Pfizer and Oxford trials was promising
Close
In a study in The Lancet Microbe, the test was found to have an average sensitivity – the ability to correctly identify those with Covid-19 – of 94.4% and a specificity – correctly identifying those without the disease – of 100%.(REUTERS)
In a study in The Lancet Microbe, the test was found to have an average sensitivity – the ability to correctly identify those with Covid-19 – of 94.4% and a specificity – correctly identifying those without the disease – of 100%.(REUTERS)

90-minute British DnaNudge Covid-19 test is accurate, Lancet study finds

By Reuters| Posted by Susmita Pakrasi | London
PUBLISHED ON SEP 18, 2020 02:07 PM IST
Faster testing could allow more people to return to work or permit testing on entry to hospital, thus slowing a second spike in coronavirus infections.
Close
Seizure by an Indian agency of large quantities of potent medicines destined for the UK, Europe and the US has led the authorities in Britain and India to enhance intelligence-sharing to tackle international medicines crime. (Representative Image)(Getty Images/iStockphoto)
Seizure by an Indian agency of large quantities of potent medicines destined for the UK, Europe and the US has led the authorities in Britain and India to enhance intelligence-sharing to tackle international medicines crime. (Representative Image)(Getty Images/iStockphoto)

India, UK step up drive against illegal medicines smuggled to Britain, Europe

By Prasun Sonwalkar | Hindustan Times, London, London
UPDATED ON OCT 13, 2018 09:13 AM IST
India’s Directorate of Revenue Intelligence (DRI) recently seized 350,000 tablets of potent medicines, such as Diazepam, Tramadol and Zopiclone, destined for the UK, Europe and the US, Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) said on Thursday.
Close
SHARE
Story Saved